Lung Cancer Screening Optimization in the U.S.A multisite research center studying the delivery of lung cancer screening and associated outcomes, with particular interest in:
conducting observational studies in care delivery systems
eliminating disparities in deaths from lung cancer
optimizing benefits & reducing harms of screening
LOTUS is comprised of five US integrated healthcare systems representing diverse populations and communities. The research team includes investigators in each healthcare system as well as Harvard and University of Michigan.
LOTUS (Lung Cancer Screening Optimization in the United States) is one of three research centers in the National Cancer Institute-funded Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium.Learn more about LOTUS